Police & Firemen's Retirement System of New Jersey’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184K Buy
13,831
+3,856
+39% +$37.6K ﹤0.01% 2381
2026
Q1
$92.9K Hold
9,975
﹤0.01% 2545
2025
Q4
$74.8K Sell
9,975
-2,888
-22% -$29.3K ﹤0.01% 2678
2025
Q3
$112K Buy
12,863
+2,845
+28% +$17K ﹤0.01% 2521
2025
Q2
$37.2K Hold
10,018
﹤0.01% 2889
2025
Q1
$32.4K Hold
10,018
﹤0.01% 2846
2024
Q4
$55.8K Buy
+10,018
New +$78.6K ﹤0.01% 2721

Other funds holding FDMT

Police & Firemen's Retirement System of New Jersey's FDMT Position: Q2 2026 in Review

Police & Firemen's Retirement System of New Jersey increased its 4D Molecular Therapeutics (FDMT) stake by 39% in Q2 2026, buying an estimated $37.6K and bringing the position to 13,831 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

Police & Firemen's Retirement System of New Jersey first reported a position in FDMT in Q4 2024 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • Police & Firemen's Retirement System of New Jersey held 13,831 shares of 4D Molecular Therapeutics worth $184K as of Q2 2026.
  • Police & Firemen's Retirement System of New Jersey bought 3,856 4D Molecular Therapeutics shares in Q2 2026, an estimated $37.6K.
  • 4D Molecular Therapeutics made up ﹤0.01% of Police & Firemen's Retirement System of New Jersey's portfolio in Q2 2026, its #2381 holding.
  • Police & Firemen's Retirement System of New Jersey first reported a position in 4D Molecular Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 51 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on Police & Firemen's Retirement System of New Jersey's 13F filing for Q2 2026, filed 23 Jul 2026.